Bacterial Vaginosis, Atopobium vaginae and Nifuratel

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|7|1|36-40

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.7, Iss.1, 2012-02, pp. : 36-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Probiotic strategies for the treatment and prevention of bacterial vaginosis

By MacPhee Roderick A   Hummelen Ruben   Bisanz Jordan E   Miller Wayne L   Reid Gregor  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 2985-2995

Informa Healthcare

Access to resources Recommend Favorite

Hormonal contraceptive use appears to reduce bacterial vaginosis risk

By  

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Intravaginal clindamycin is `as effective' as oral metronidazole in the treatment of women with bacterial vaginosis

By  

Inpharma, Vol. 1, Iss. 1255, 2000-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Nifuratel: Allergic contact dermatitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1197, 2008-01 ,pp. : 33-34

Adis International

Access to resources Recommend Favorite

Proteomics of bacterial pathogens

By Cash Phillip  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 5, 2008-05 ,pp. : 461-473

Informa Healthcare

Access to resources Recommend Favorite